Project description:Acute myeloid leukemia (AML) is a heterogeneous disease in respect of molecular aberrations and prognosis. We used gene expression profiling of 562 patients treated in the German AMLCG 1999 trial to develop a gene signature that predicts survival in AML. Analysis of 562 samples (140 HGU-133plus2; 422 HGU-133A; 422 HGU-133B) from adult patients with acute myeloid leukemia (AML).
Project description:This SuperSeries is composed of the following subset Series: GSE28314: Genome-wide study of DNA methylation in AML by MeDIP-seq GSE34722: Gene expression profiling of Acute Myeloid Leukemia (AML) samples Refer to individual Series
